Collectively, these findings demonstrate that ELOVL2 maybe upregulates AR protein expression by inhibiting the ubiquitin-proteasome pathway, thereby enhancing AR signaling and contributing to enzalutamide resistance in PCa cells. The gene discussed is AR; the disease is posterior cortical atrophy.